Novacyt gearing up for hearing in DHSC litigation
Novacyt S.A. (CDI)
53.30p
16:09 31/01/25
-2.02%
-1.10p
Molecular diagnostics specialist Novacyt updated the market on legal proceedings between itself and its subsidiary Primer Design against the Department of Health and Social Care (DHSC) on Friday.
FTSE AIM All-Share
718.13
16:55 31/01/25
n/a
n/a
Health Care Equipment & Services
11,119.80
16:39 31/01/25
0.43%
47.52